Knuts, not sure it's a question of "where ARE we going wrong" but more "where WERE we going wrong". My sense was that Mullan, Jenkins and company were too wet behind the ears in terms of establishing a realistic, achievable business strategy. Sure, they had lots of hurdles to overcome including the Jonnie Williams political news, past baggage from non-contributing BOD and leadership, etc. Ultimately, they were never able to convince a credible $ source that this company was worth the investment and that's all that eventually mattered. That is THEIR failure. I think they exacerbated the problem by hooking up with the death spiral financing. They would have been better off closing doors or at least suspending operations temporarily rather than the shady/naive financing approach that they took...it likely would have saved some of us considerable $.
As to why they couldn't convince others that the patent and technology is worth considerable $??? I can only assume that there may be other alternatives (as discussed here)...that may work as well or close to as well. Or, their patent(s) are simply not solid and/or protected enough. The other possibility of course is that the political clout of the FDA was too much to overcome...again, those politics can change...and had they not killed the company with the shady financing, perhaps we could have lived to fight another day.
